➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Medtronic
Johnson and Johnson
Harvard Business School
Mallinckrodt
Merck
AstraZeneca

Last Updated: August 11, 2020

DrugPatentWatch Database Preview

TRIPLE SULFA Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for TRIPLE SULFA
US Patents:0
Applicants:6
NDAs:8
Bulk Api Vendors: 95
DailyMed Link:TRIPLE SULFA at DailyMed
Drug patent expirations by year for TRIPLE SULFA

US Patents and Regulatory Information for TRIPLE SULFA

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Alpharma Us Pharms TRIPLE SULFA triple sulfa (sulfabenzamide;sulfacetamide;sulfathiazole) CREAM;VAGINAL 087864-001 Sep 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Pharmaderm TRIPLE SULFA triple sulfa (sulfabenzamide;sulfacetamide;sulfathiazole) TABLET;VAGINAL 088462-001 Jan 3, 1985 DISCN No No   Start Trial   Start Trial   Start Trial
Alpharma Us Pharms TRIPLE SULFA trisulfapyrimidines (sulfadiazine;sulfamerazine;sulfamethazine) SUSPENSION;ORAL 080280-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Lederle TRIPLE SULFAS trisulfapyrimidines (sulfadiazine;sulfamerazine;sulfamethazine) SUSPENSION;ORAL 006920-003 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Fougera TRIPLE SULFA triple sulfa (sulfabenzamide;sulfacetamide;sulfathiazole) CREAM;VAGINAL 086424-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Perrigo New York TRIPLE SULFA triple sulfa (sulfabenzamide;sulfacetamide;sulfathiazole) CREAM;VAGINAL 087285-001 Nov 15, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Dow
Boehringer Ingelheim
AstraZeneca
Harvard Business School
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.